Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)

Dedifferentiated endometrial carcinoma (DDEC) is defined as an undifferentiated carcinoma admixed with differentiated endometrioid carcinoma (Grade 1 or 2). It has poor prognosis compared with Grade 3 endometrioid adenocarcinoma and is often associated with the loss of mismatch repair (MMR) proteins...

Descripción completa

Detalles Bibliográficos
Autores principales: Ono, Ruriko, Nakayama, Kentaro, Nakamura, Kohei, Yamashita, Hitomi, Ishibashi, Tomoka, Ishikawa, Masako, Minamoto, Toshiko, Razia, Sultana, Ishikawa, Noriyoshi, Otsuki, Yoshiro, Nakayama, Satoru, Onuma, Hideyuki, Kurioka, Hiroko, Kyo, Satoru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696376/
https://www.ncbi.nlm.nih.gov/pubmed/31370215
http://dx.doi.org/10.3390/ijms20153744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6696376/
https://www.ncbi.nlm.nih.gov/pubmed/31370215
http://dx.doi.org/10.3390/ijms20153744

Ejemplares similares